Search research articles
Contact Us
Filters
Showing results (1-10 of 186) with videos related to
Page
of 19
Sort By:
The Journal of Clinical Investigation
|
July 11, 2006
New insights into the regulation of inflammation by adenosine
Joel Linden
American Journal of Physiology. Cell Physiology
|
May 19, 2006
Adenosine metabolism and cancer. Focus on "Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatases and reducing ERK1/2 activity via a novel pathway"
Joel Linden
Cardiovascular Drugs and Therapy
|
May 1, 2012
Statins counter the effects of hyperlipidemia on iNKT cells: Editorial to: "Statin-induced immunomodulation alters peripheral invariant natural killer T-cell prevalence in hyperlipidemic patients" by E. Nakou et al
Joel Linden
Molecular Pharmacology
|
February 11, 2005
Adenosine in tissue protection and tissue regeneration
Joel Linden
Advances in Pharmacology (San Diego, Calif.)
|
May 19, 2011
Regulation of leukocyte function by adenosine receptors
Joel Linden
Molecular Pharmacology
|
October 23, 2002
Autoregulation of cyclic AMP in vascular smooth muscle: a role for adenosine receptors
Joel Linden
Science (New York, N.Y.)
|
December 16, 2006
Cell biology. Purinergic chemotaxis
Joel Linden
Science Signaling
|
May 30, 2013
Adenosine promotes tumor metastasis
Joel Linden
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 17, 2012
Role of adenosine in response to vascular inflammation
Joel Linden
Nature
|
July 13, 2012
Translational medicine: Longer life for artificial joints
Joel Linden
Page
of 19
Search research articles
Search
Showing results (1-10 of 186) with videos related to
Sort By:
Page
of 19
The Journal of Clinical Investigation
|
July 11, 2006
New insights into the regulation of inflammation by adenosine
Joel Linden
American Journal of Physiology. Cell Physiology
|
May 19, 2006
Adenosine metabolism and cancer. Focus on "Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatases and reducing ERK1/2 activity via a novel pathway"
Joel Linden
Cardiovascular Drugs and Therapy
|
May 1, 2012
Statins counter the effects of hyperlipidemia on iNKT cells: Editorial to: "Statin-induced immunomodulation alters peripheral invariant natural killer T-cell prevalence in hyperlipidemic patients" by E. Nakou et al
Joel Linden
Molecular Pharmacology
|
February 11, 2005
Adenosine in tissue protection and tissue regeneration
Joel Linden
Advances in Pharmacology (San Diego, Calif.)
|
May 19, 2011
Regulation of leukocyte function by adenosine receptors
Joel Linden
Molecular Pharmacology
|
October 23, 2002
Autoregulation of cyclic AMP in vascular smooth muscle: a role for adenosine receptors
Joel Linden
Science (New York, N.Y.)
|
December 16, 2006
Cell biology. Purinergic chemotaxis
Joel Linden
Science Signaling
|
May 30, 2013
Adenosine promotes tumor metastasis
Joel Linden
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 17, 2012
Role of adenosine in response to vascular inflammation
Joel Linden
Nature
|
July 13, 2012
Translational medicine: Longer life for artificial joints
Joel Linden
Page
of 19